Electronic cigarettes: a survey of users
- Out of the Ashes: The Life, Death, and Rebirth of the "Safer" Cigarette in the United States. Fairchild, Amy; Colgrove, James // American Journal of Public Health;Feb2004, Vol. 94 Issue 2, p192
From 1964 through the early 1980s, both federal and voluntary agencies endorsed the concept of "safer" cigarettes. Beginning in the mid-1980s, several factors, including revelations of tobacco industry malfeasance, the development of nicotine replacement therapy, and the reconceptualization of...
- Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. // British Dental Journal;7/11/2014, Vol. 217 Issue 1, p31
'I am still not smoking'; e-cigarettes were more effective than nicotine replacement therapy (NRT) or no aid.
- Union calls for immediate regulation of e-cigarette products. // Hem/Onc Today;1/25/2014, Vol. 15 Issue 2, p9
The article reports on the International Union Against Tuberculosis and Lung Health's call for urgent regulation of electronic cigarettes (e-cigarettes) and electronic nicotine delivery systems due to concerns about safety and chemical content.
- E-cigarettes: Facts and legal status. Sinniah, Davendralingam; Khoo, Erwin Jiayuan // International E-Journal of Science, Medicine & Education;Nov2015, Vol. 9 Issue 3, p10
The sale of tobacco-based cigarettes has declined in western countries, and 'Big Tobacco' is trying to make up the deficit in profits from the developing world. The recent introduction of e-cigarette, in which they have invested both their hopes and their finances, has been a boon to them as it...
- Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Smith, Stevens S.; Jorenby, Douglas E.; Leischow, Scott J.; Nides, Mitchell A.; Rennard, Stephen I.; Johnston, J. Andrew; Jamerson, Brenda; Fiore, Michael C.; Baker, Timothy B. // Nicotine & Tobacco Research;Feb2003, Vol. 5 Issue 1, p99
Investigates the efficacy of bupropion sustained-release and the nicotine patch for smoking cessation in subgroups of smokers at risk for relapse. Brief individual cessation counseling; Comparison between placebo tablet and bupropion sustained-release; First-line treatment for smoking that has...
- Use of Sustained-Release Bupropion in Specific Patient Populations for Smoking Cessation. Tonstad, S. // Drugs;2002 Supplement 2, Vol. 62 Issue 11, p37
Smoking cessation trials of sustained-release bupropion (bupropion SR) were initially conducted in a general population of smokers who were motivated to quit smoking. Bupropion SR has also been found to be a useful treatment of tobacco dependence in various special populations of smokers who...
- Clinical Efficacy of Bupropion in the Management of Smoking Cessation. Jorenby, D. // Drugs;2002 Supplement 2, Vol. 62 Issue 11, p25
Nicotine addiction is a chronic relapsing condition that can be difficult to treat. Until recently, pharmacological options for the treatment of tobacco dependence were primarily limited to nicotine replacement therapy (NRT). Sustained-release bupropion (bupropion SR) is the first non-nicotine...
- Pharmacokinetic Optimisation of Sustained-Release Bupropion for Smoking Cessation. Johnston, A.J.; Ascher, J.; Leadbetter, R.; Schmith, V.D.; Patel, D.K.; Durcan, M.; Bentley, B. // Drugs;2002 Supplement 2, Vol. 62 Issue 11, p11
Sustained-release bupropion (bupropion SR) is a unique, non-nicotine smoking cessation aid that is hypothesised to act upon neurological pathways involved in nicotine dependence. Pharmacokinetic and metabolism studies reveal that bupropion SR is metabolised by multiple pathways with no single...
- GP helps smokers choose how to quit. // Pulse;11/24/2003, Vol. 63 Issue 47, p12
Reports on the development of a booklet by Doctor Richard Thomas to help smokers quit from smoking in Wales. Advantages and disadvantages of various options for smoking management; Existence of products for smoking cessation.